These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22555922)

  • 1. Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on bioanalysis by liquid chromatography/tandem mass spectrometry.
    Zheng N; Fung EN; Buzescu A; Arnold ME; Zeng J
    Rapid Commun Mass Spectrom; 2012 Jun; 26(11):1291-304. PubMed ID: 22555922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects.
    Xia YQ; Jemal M
    Rapid Commun Mass Spectrom; 2009 Jul; 23(14):2125-38. PubMed ID: 19517478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry.
    Ismaiel OA; Zhang T; Jenkins RG; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3303-16. PubMed ID: 21056019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic evaluation of supported liquid extraction in reducing matrix effect and improving extraction efficiency in LC-MS/MS based bioanalysis for 10 model pharmaceutical compounds.
    Jiang H; Cao H; Zhang Y; Fast DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 891-892():71-80. PubMed ID: 22410088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of glucocorticoid residues in edible tissues of swine, cattle, sheep, and chicken.
    Chen D; Tao Y; Liu Z; Liu Z; Wang Y; Huang L; Yuan Z
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2010 Oct; 27(10):1363-71. PubMed ID: 20658401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assay.
    Yuan L; Fu Y; Zhang D; Xia YQ; Peng Q; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():60-8. PubMed ID: 25151331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a gamma-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions.
    Gu H; Deng Y; Wang J; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2319-26. PubMed ID: 20674522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective screening approach to select esterase inhibitors used for stabilizing ester-containing prodrugs analyzed by LC-MS/MS.
    Fung EN; Zheng N; Arnold ME; Zeng J
    Bioanalysis; 2010 Apr; 2(4):733-43. PubMed ID: 21083271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating regulatory-compliant wide dynamic range bioanalytical assays using chip-based nanoelectrospray tandem mass spectrometry.
    Wickremsinhe ER; Ackermann BL; Chaudhary AK
    Rapid Commun Mass Spectrom; 2005; 19(1):47-56. PubMed ID: 15570573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of camostat and its metabolites in human plasma - Preservation of samples and quantification by a validated UHPLC-MS/MS method.
    Sørensen LK; Hasselstrøm JB; Gunst JD; Søgaard OS; Kjolby M
    Clin Biochem; 2021 Oct; 96():56-62. PubMed ID: 34252447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of curcumin diethyl disuccinate and its active metabolite curcumin in rat plasma by LC-MS/MS: Application of esterase inhibitors in the stabilization of an ester-containing prodrug.
    Ratnatilaka Na Bhuket P; Niwattisaiwong N; Limpikirati P; Khemawoot P; Towiwat P; Ongpipattanakul B; Rojsitthisak P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():301-310. PubMed ID: 27595650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of the cytidine deaminase inhibitor tetrahydrouridine (THU) in mouse plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Parise RA; Egorin MJ; Eiseman JL; Joseph E; Covey JM; Beumer JH
    Rapid Commun Mass Spectrom; 2007; 21(13):1991-7. PubMed ID: 17526067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of cyclosporine, tacrolimus, sirolimus and everolimus by liquid chromatography coupled to electrospray ionization and tandem mass spectrometry: assessment of matrix effects and assay performance.
    Vethe NT; Gjerdalen LC; Bergan S
    Scand J Clin Lab Invest; 2010 Dec; 70(8):583-91. PubMed ID: 21039189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of drugs in equine plasma using automated on-line solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry.
    Kwok WH; Leung DK; Leung GN; Wan TS; Wong CH; Wong JK
    J Chromatogr A; 2010 May; 1217(19):3289-96. PubMed ID: 20122690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mobile phase pH, aqueous-organic ratio, and buffer concentration on electrospray ionization tandem mass spectrometric fragmentation patterns: implications in liquid chromatography/tandem mass spectrometric bioanalysis.
    Wang J; Aubry A; Bolgar MS; Gu H; Olah TV; Arnold M; Jemal M
    Rapid Commun Mass Spectrom; 2010 Nov; 24(22):3221-9. PubMed ID: 20972995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive screening of acidic and neutral drugs in equine plasma by liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Tang FP; Wan TS; Wong AS
    J Chromatogr A; 2008 May; 1189(1-2):426-34. PubMed ID: 18054785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a stabilizer cocktail of N-ethylmaleimide and phenylmethanesulfonyl fluoride to concurrently stabilize the disulfide and ester containing compounds in a plasma LC-MS/MS assay.
    Yuan L; Jian W; Zhang D; Aubry AF; Arnold ME
    J Pharm Biomed Anal; 2014 Jan; 88():552-61. PubMed ID: 24211707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of liquid chromatography/quadrupole-linear Ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater.
    Bueno MJ; Agüera A; Gómez MJ; Hernando MD; García-Reyes JF; Fernandez-Alba AR
    Anal Chem; 2007 Dec; 79(24):9372-84. PubMed ID: 18001124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.